Provided by Tiger Trade Technology Pte. Ltd.

IceCure Medical Ltd.

0.3748
-0.0153-3.92%
Post-market: 0.40000.0252+6.72%19:25 EDT
Volume:847.42K
Turnover:321.39K
Market Cap:30.43M
PE:-1.58
High:0.4114
Open:0.4114
Low:0.3700
Close:0.3901
52wk High:1.40
52wk Low:0.3700
Shares:81.18M
Float Shares:53.31M
Volume Ratio:0.68
T/O Rate:1.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2368
EPS(LYR):-0.2368
ROE:-188.78%
ROA:-71.29%
PB:3.36
PE(LYR):-1.58

Loading ...

IceCure prices $4.0 million registered direct offering at $0.50 per share; adds Series B and C warrants at $0.55 exercise price

Reuters
·
Mar 26

Icecure Announces Pricing of $4.0 Million Registered Direct Offering and Concurrent Private Placement

THOMSON REUTERS
·
Mar 26

IceCure Medical files Form 3 initial beneficial ownership statement; director Ron Mayron reports 296,631 ordinary shares

Reuters
·
Mar 26

IceCure Medical; CEO and director Eyal Shamir files initial beneficial ownership statement```

Reuters
·
Mar 26

IceCure Medical Posts Strong 5-Year Kidney Cancer Cryoablation Data From ICESECRET Trial

TIPRANKS
·
Mar 25

IceCure Medical reports results from clinical trial of ProSense for SRMs

TIPRANKS
·
Mar 25

IceCure reports ICESECRET ProSense kidney cancer trial; recurrence-free rate rises to 89.4% for tumors ≤3 cm

Reuters
·
Mar 25

Icecure Medical Ltd - 89.4% Recurrence-Free Rate for Tumors ≤3 Cm, 83.9% for General Population at 4 Years

THOMSON REUTERS
·
Mar 25

Icecure Reports Positive 5-Year Top-Line Results From Icesecret Kidney Cancer Cryoablation Study: 89.4% and 83.9% Recurrence-Free Rates

THOMSON REUTERS
·
Mar 25

IceCure Medical Names New CFO and Plans Key Leadership Changes Amid ProSense® Growth

TIPRANKS
·
Mar 24

IceCure names Meir Peleg CFO effective May 17, 2026

Reuters
·
Mar 24

BRIEF-Icecure Appoints Meir Peleg As Chief Financial Officer

Reuters
·
Mar 24

Icecure Appoints Meir Peleg as Chief Financial Officer

THOMSON REUTERS
·
Mar 24

Press Release: IceCure Appoints Meir Peleg as Chief Financial Officer

Dow Jones
·
Mar 24

Icecure Medical Rides FDA, ASBRS Wins to Growth

TIPRANKS
·
Mar 18

IceCure Medical Director Li Haixiang Resigns Effective March 17, 2026

Reuters
·
Mar 18

IceCure Medical reports FY25 EPS 24c vs 30c last year

TIPRANKS
·
Mar 17

Israel's IceCure Medical 2025 gross margin falls to 36% on higher costs

Reuters
·
Mar 17

Icecure Medical Q4 EPS $(0.06) Misses $(0.04) Estimate, Sales $1.279M Miss $1.900M Estimate

Benzinga
·
Mar 17

IceCure FY 2025 net loss narrows 5% to USD 15.06 million

Reuters
·
Mar 17